Evidence map›Paper›PMID 38138481›Full record

ArticleMolecules (Basel, Switzerland)2023

NMR and Docking Calculations Reveal Novel Atomistic Selectivity of a Synthetic High-Affinity Free Fatty Acid vs. Free Fatty Acids in Sudlow's Drug Binding Sites in Human Serum Albumin.

Themistoklis Venianakis, Alexandra Primikyri, Till Opatz, Stefan Petry, Georgios Papamokos, Ioannis P Gerothanassis

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. 4-Ethyl phenyl sulfate binding to human serum albumin.Protein science : a publication of the Protein Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Materials today. Bio · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Themistoklis VenianakisSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece.
Alexandra PrimikyriSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece.
Till OpatzDepartment of Chemistry, Johannes Gutenberg-University, Duesbergweg, 10-14, 55128 Mainz, Germany.ORCID 0000-0002-3266-4050
Stefan PetrySanofi-Aventis Deutschland GmbH, Integrated Drug Discovery, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
Georgios PapamokosSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece.ORCID 0000-0002-7671-2798
Ioannis P GerothanassisSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece.ORCID 0000-0002-3745-9902
University of Ioannina · GRHarvard University · USJohannes Gutenberg University Mainz · DESanofi (Germany) · DE

Funding

Hellenic Foundation for Research and Innovation (H.F.R.I.) 2050
6 · The paper itself

Abstract

Saturation transfer difference (STD), inter-ligand NOEs (INPHARMA NMR), and docking calculations are reported for investigating specific binding sites of the high-affinity synthetic 7-nitrobenz-2-oxa-1,3-diazoyl-4-C

Indexed as

Fatty Acids, NonesterifiedSerum Albumin, HumanAmino AcidsBinding SitesFatty AcidsHumansIbuprofenMagnetic Resonance SpectroscopyProtein BindingSerum AlbuminWarfarinAmino AcidsFatty AcidsFatty Acids, NonesterifiedIbuprofenSerum AlbuminSerum Albumin, HumanWarfarindocking calculationsHSAINPHARMA NMRNBD-C12 FASTD NMR

Identifiers

PMID38138481
PMCPMC10745614
OpenAlexW4389436011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.